Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Flux, the AI hardware engineer, announces $37M in new investment
-
Boosterthon Tops $1 Billion Raised for Education
-
Proposal of the Shareholders’ Nomination Committee on the Composition and Remuneration of the Board of Directors of Oma Savings Bank Plc
-
MEDIROM Launches Partnership with Tools for Humanity in February; Projects Approximately $39 Million in Income Before Income Taxes Over Two Years Following Expansion to 3,000 Nationwide Locations
-
Edible Garden to Showcase Zero-Waste Inspired® Platform and Announce Major Nutrition Platform Expansion at Natural Products Expo West® 2026 in Anaheim, California, March 3–6
-
FullPAC, Inc. Issues Spring 2026 Chairman’s Letter
-
Milengo Repositions as an AI-Led Language Solutions Integrator
-
Rapid Index Checker Launches Bulk Google Index Checker Tool for URL Verification and Indexing Status Monitoring
-
Ghacks Technology News Removes All Ads and Launches New Dutch and German Editions
-
DuPlooy Law Announces Expansion to International Business Legal Services from Calgary
-
Renewal Fuels, Inc. (OTC: RNWF), Operating as American Fusion, Provides Patent Portfolio Update; 20 Texatron™ “Clam-Shell” Applications Filed; Significant Portfolio Expansion Planned for 2026
-
Dental Patient Monitors Announces Launch of New Website
-
OPKO Health to Participate in the Jefferies Biotech on the Beach Summit
-
LiqTech International Announces Financial Results for Fourth Quarter and Full Year 2025
-
Dycom Industries, Inc. to Participate in Upcoming Investor Conferences
-
Super Technologies Strengthens Sportradar Partnership to Accelerate Its Global Growth Strategy
-
Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale
-
Nkarta to Participate in March Investor Conferences
-
ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
-
Foremost Clean Energy Announces Signing of Exploration Agreement with Kiciwapa Cree Nation, Manitoba
-
BIGC Partners with Bauer Lab to Expand K-POP in the Middle East
-
VisionWave Holdings, Inc. Enters into Memorandum of Understanding to Pursue German Defense Market Opportunities
-
Next-Generation Reliability Fuels Rapid Wi-Fi 8 Adoption, Reaching 82.8 Million Annual Shipments by 2030
-
Vertex to Present at Upcoming Conferences
-
NOTICE OF ORDINARY AND EXTRAORDINARY GENERAL MEETINGS OF SHAREHOLDERS OF ECONOCOM SE OF 31 MARCH 2026
-
Tidewave Bio Appoints Prof. Alexander M.M. Eggermont, MD, PhD, as Head of Clinical Advisory Board
-
Bitget Wallet Expands Into AI Agent Capabilities With Skill Beta
-
Miracle Pay Begins Global Rollout, Enabling Crypto Payments at the Point of Sale
-
Annual Financial Report – Solar Funding II Limited – year ended 31 October 2025
-
Bakkt Announces Pricing of $48.125 Million Registered Direct Offering
-
Boralex reports net earnings of $33 million for fiscal 2025 marked by the commissioning of large-scale projects in Canada and the United Kingdom
-
Caliber Completes Sale of Holiday Inn Ocotillo for $13.0 Million and Positions Caliber Hospitality Trust for 2026–2027 Expansion
-
Credicorp Ltd.: Credicorp Announces Director Nominees for the 2026 Annual General Meeting of Shareholders
-
Barrick’s 2025 Annual Information Form and Other Documents Now Available
-
How to Join the Johnson Fistel, PLLP Investigation if You Purchased Duolingo, Inc. (DUOL) and Suffered Losses
-
Issue of Equity
-
TransAlta Enters Memorandum of Understanding for Data Centre Development at Keephills Site with Potential to Scale Up to 1 GW
-
TransAlta to Host Investor Day
-
TransAlta Reports Fourth Quarter and Year End 2025 Results, Announces Data Centre Agreement, Declares Dividend Increase and Provides 2026 Outlook
-
OrthoPediatrics to Participate in Upcoming Conferences
-
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results
-
Press Release: Sanofi and Regeneron’s Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms despite treatment
-
Brunswick Exploration Announces Appointment of Vice President – International Projects
-
Telix Joins Forces with University Hospital Essen on PROMISE-PET: Optimizing Patient Management through AI-enabled PSMA-PET Imaging
-
Brunswick Exploration Files Maiden Mineral Resource Estimate NI 43-101 Technical Report for Mirage Project
-
ADARx Pharmaceuticals Presents Onvuzosiran Data Supporting Potential for Sustained Attack-Free Rates with Reduced Treatment Burden in Patients with HAE
-
Range Increases Quarterly Dividend By 11%
-
Boralex and Six Nations of the Grand River Development Corporation Commission Canada’s Largest Operating Battery Storage Facility
-
Dupixent® (dupilumab) Recommended for EU Approval to Treat Chronic Spontaneous Urticaria (CSU) in Young Children with Ongoing Symptoms Despite Treatment
-
Flare Therapeutics Presents Updated FX-909 Phase 1A Data in Late-Breaking Oral Presentation at 2026 ASCO Genitourinary Cancers Symposium

